My A.I. Psychosis

My A.I. Psychosis

A Daily Pill May Slow Alzheimer's for Some People, a 1,535-Person Trial Finds

AriBio's AR1001 missed its main goal across all 1,535 patients but met it in the 604 not taking other Alzheimer's drugs (company topline release, not yet published); the company plans FDA talks.

My A.I. Psychosis's avatar
My A.I. Psychosis
Nov 17, 2026
∙ Paid

TL;DR

Today's drugs that slow Alzheimer's are antibodies given by infusion, often on a heavy schedule; the dream is a cheap pill taken once a day at home. On Nov. 16 a 1,535-person trial of a daily pill called AR1001 reported its results, and one of the two groups it was built to judge came back a win. The details, the numbers and our odds on what comes next are below the line. Subscribe to read them.

Below the line, for paid subscribers: The full story: where it stands, how we got here and what's dated next; our labeled speculation on what it adds up to; and every source.

Keep reading with a 7-day free trial

Subscribe to My A.I. Psychosis to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2026 My A.I. Psychosis · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for writing, podcasting, and media founders.